AlphaFold predicted structure
TRMT5 · Q32P41

Mean pLDDT
80.8/ 100
Confident
509 residues
Confidence breakdown
- Very high(≥ 90)64%
- Confident(70–90)12%
- Low(50–70)4%
- Very low(< 50)19%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
tRNA methyltransferase 5
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Hereditary neuropathy or pain disorder
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalAdult onset hereditary spastic paraplegia
BIALLELIC, autosomal or pseudoautosomalAtaxia and cerebellar anomalies - narrow panel
BIALLELIC, autosomal or pseudoautosomalCombined oxidative phosphorylation defect type 26
neurodegenerative disease
inborn mitochondrial metabolism disorder
mitochondrial disease
hereditary disease
liver disorder
Intellectual disability
urticaria
primary angle-closure glaucoma
diabetes mellitus
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
tRNA (guanine(37)-N(1))-methyltransferase
Involved in mitochondrial tRNA methylation (PubMed:26189817). Specifically methylates the N1 position of guanosine-37 in various tRNAs. Methylation is not dependent on the nature of the nucleoside 5' of the target nucleoside. This is the first step in the biosynthesis of wybutosine (yW), a modified base adjacent to the anticodon of tRNAs and required for accurate decoding
TRMT5 · Q32P41

Mean pLDDT
80.8/ 100
Confident
509 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0